96. Bubley, G.J., et al., Eligibility and response guidelines for phase II clinical trials in androgen- independent prostate cance r: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol, 1999. 17(11): p. 3461-7. 97. Vergote, I., et al., Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst, 2000. 92(18): p. 1534-5.